ARTICLE | Company News
J&J, Eiger deal
January 5, 2015 8:00 AM UTC
Eiger’s EB Pharma LLC subsidiary received exclusive rights to tipifarnib for virology and an undisclosed clinical-stage back-up compound from the pharma’s Janssen Pharmaceutica N.V. unit. EB plans to ...